BRIEF published on 03/01/2024 at 07:05, 9 months 21 days ago Alzchem Group AG Reports Significant EBITDA Growth and Optimistic 2024 Forecast Dividend Increase 2024 Forecast Alzchem Group AG EBITDA Growth Specialty Chemicals
BRIEF published on 03/01/2024 at 07:05, 9 months 21 days ago Alzchem Group AG annonce une croissance significative de l'EBITDA et des prévisions optimistes pour 2024 Prévisions 2024 Augmentation Du Dividende Alzchem Group SA Croissance Du BAIIA Produits Chimiques Spécialisés
PRESS RELEASE published on 03/01/2024 at 07:00, 9 months 21 days ago Alzchem Group AG: EBITDA increase of 32.4 % to EUR 81.4 million – continuing on the road to success Alzchem Group AG reports a 32.4% increase in EBITDA to EUR 81.4 million in 2023, highlighting growth in specialty chemicals and plans for dividend increase EBITDA Dividend Increase 2023 Financial Results Alzchem Group AG Specialty Chemicals
PRESS RELEASE published on 10/27/2023 at 11:56, 1 year 1 month ago Original-Research: Alzchem Group AG (von Sphene Capital GmbH): Buy
PRESS RELEASE published on 10/26/2023 at 06:55, 1 year 1 month ago Alzchem Group AG significantly increases EBITDA by 19.8% to EUR 56.3 million in the nine-month period 2023
PRESS RELEASE published on 10/19/2023 at 08:51, 1 year 2 months ago Original-Research: Alzchem Group AG (von Sphene Capital GmbH): Buy
PRESS RELEASE published on 10/18/2023 at 16:23, 1 year 2 months ago EQS-Adhoc: Alzchem Group AG raises EBITDA forecast into the range of EUR 80 million for fiscal year 2023 despite slightly lower sales expectation
PRESS RELEASE published on 09/14/2023 at 11:08, 1 year 3 months ago Alzchem Group AG: Creatine product 'Creavitalis': Wholesome taste and positive benefits for vegetarian and vegan foods
PRESS RELEASE published on 08/07/2023 at 08:26, 1 year 4 months ago Original-Research: Alzchem Group AG (von Sphene Capital GmbH): Buy
PRESS RELEASE published on 08/03/2023 at 07:00, 1 year 4 months ago Alzchem Group AG reports positive business development in the first half of 2023
Published on 12/21/2024 at 01:30, 1 day 6 hours ago Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 1 day 6 hours ago iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 1 day 8 hours ago Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/20/2024 at 23:30, 1 day 8 hours ago Boron One Announces Extension to Early Warrant Exercise Incentive Program
Published on 12/21/2024 at 00:51, 1 day 7 hours ago Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/20/2024 at 19:10, 1 day 13 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day 13 hours ago CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day 14 hours ago ARYZTA AG Announces New Board Technology Committee
Published on 12/21/2024 at 12:17, 20 hours 10 minutes ago AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 20 hours 10 minutes ago AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 14 hours ago Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day 14 hours ago Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 14 hours ago Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024
